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Background
Giant cell tumor is an osteolytic tumor  arising from  
epiphysis commonly seen in young adults
• Though it is benign it is locally aggressive or malignant
• There is slightly female predominance.
• Giant cell tumors represent 5% of bone neoplasm's.
• They typically occur in patients between the age of 20 and 
40 years 
• Location – distal femur (most common); distal radius 
(most aggressive); sacrum and pelvis (very rare)
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Clinical features
• Swelling
• Mild pain, usually pain is not presenting feature 
• Skin over swelling  is stretched
• No dilated veins
• Tenderness is moderate
• Egg shell cracking sensation may be present
• Limitations of joint movement is not seen till late 
stage
• Joint is usually not invaded 
• Pathological fracture is usually a late feature 
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Radiology 
• Osteolytic area is seen  near epiphysis
• Cortex is expanded
• No periosteal bone formation is seen
• Thin septa of bone traverses the interior  and 
produces a soap bubble appearance 
• Cortex may be disrupted in late stage
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Campanacci’s grading
• Grade 1 cystic lesion
• Grade 2 cortex is thin but not perforated
• Grade 3 cortex is  perforated  with 
extension  into soft tissues
• Giant cell tumors usually are solitary 
lesions; however, 1% to 2% may be 
synchronously or metachronously
multicentric. 
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Pulmonary metastases
• The overall mortality rate from the disease, for 
patients with it, is approximately 15%. Patients 
with recurrent lesions or primary lesions that 
appear aggressive on X-ray, graphically are at 
higher risk for pulmonary metastases. 
• Malignant giant cell tumors represent less than 
5% of the cases and are classified as primary or 
secondary
• Primary malignant giant cell tumors are 
extremely rare
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Microscopically
• Giant cell tumors are 
composed of many 
multinucleated giant cells 
(typically 40 to 60 nuclei 
per cell) in a sea of 
mononuclear stromal cells. 
Cardiosurgery - Skopje
Principles of tumor treatment
• Tumor is invasive and aggressive 
• It commonly reoccurs, and may become malignant  after 
unsuccessful removal
• Recurrence is treated  with enblock excision
• Possible bleeding due to rich neo-revascularization
• Pre-operative angiography and neo-vascular net coiling
• Enblock excision - eroded tumor cortex and soft tissue 
indurations
• Usage of adjuvants – bone cement, for killing the 
remaining tumor cells
• Usage of bone grafts
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Case report - clinical manifestation
• Giant cell tumour in 34 year old man. 
2-year history of worsening low back pain that radiated    
down his left leg
20kg loosing on weight
2 years treated as discus hernia
• X Ray – typical for pelvic giant cell 
• 64 MSCT scan – giant tumor of the left ossis illei,with a 
rich neo-vascularisation
CT-guided biopsy confirmed the 
diagnosis 
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Pelvis
• GCT often vascular
– Pre-op angiography
– ? embolization
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Angiography and interventional coiling of the 
neo-vascular net of a.iliaca int.l.sin
Due to large lumen of the pathologic vessels – coiling was possible in 
combination with bio-glue Artex –vascular sielant
Diagnostic                                                                             Intervention
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Surgery – team’s approach - vascular and 
orthopaedics
Vascular surgeon performed vascular preservation of the operative field
The tumor was eradicated by combination of enblock resection and 
curettage. 
Bone cement was used for remodeling of sacral and illeal bone as well as 
killing of residual tumor cells
At the end two Kirschner’s needles were used for strengthening of the 
bone cement 
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Postoperative period
• Post-operative period
• 1,5 l. blood lost ( need of 6 EK)
• Early mobilization
• Complete functional recovery of the left leg
• Control X Ray of the lung b.o.
• Follow up period 9 months
1st postop. day
After 3 months
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Summary
• Locally malignant
• Affects young adults, high degree of 
invalidity
• Giant cells are characterized with a 
rich neo-vascular net with topic 
position on pelvic bones
• Multidisciplinary approach in such 
cases results with excellent 
postoperative success, even in 
patients with progressive disease 
stadium
• Pre-operative coiling of the neo-
vascular net is very important for 
intra-operative and post-operative 
bleeding prevention
